1
|
Gudala K, Bansal D, Schifano F and
Bhansali A: Diabetes mellitus and risk of dementia: A meta-analysis
of prospective observational studies. J Diabetes Investig.
4:640–650. 2013.PubMed/NCBI View Article : Google Scholar
|
2
|
Cheng G, Huang C, Deng H and Wang H:
Diabetes as a risk factor for dementia and mild cognitive
impairment: A meta-analysis of longitudinal studies. Intern Med J.
42:484–491. 2012.PubMed/NCBI View Article : Google Scholar
|
3
|
Strachan MW, Price JF and Frier BM:
Diabetes, cognitive impairment, and dementia. BMJ.
336(6)2008.PubMed/NCBI View Article : Google Scholar
|
4
|
Profenno LA, Porsteinsson AP and Faraone
SV: Meta-analysis of Alzheimer's disease risk with obesity,
diabetes, and related disorders. Biol Psychiatry. 67:505–512.
2010.PubMed/NCBI View Article : Google Scholar
|
5
|
Dybjer E, Nilsson PM, Engström G, Helmer C
and Nägga K: Pre-diabetes and diabetes are independently associated
with adverse cognitive test results: A cross-sectional,
population-based study. BMC Endocr Disord. 18(91)2018.PubMed/NCBI View Article : Google Scholar
|
6
|
Cholerton B, Baker LD, Montine TJ and
Craft S: Type 2 diabetes, cognition, and dementia in older adults:
Toward a precision health approach. Diabetes Spectr. 29:210–219.
2016.PubMed/NCBI View Article : Google Scholar
|
7
|
Zheng M, Chang B, Tian L, Shan C, Chen H,
Gao Y, Huang G and Zhang M: Relationship between inflammatory
markers and mild cognitive impairment in Chinese patients with type
2 diabetes: A case-control study. BMC Endocr Disord.
19(73)2019.PubMed/NCBI View Article : Google Scholar
|
8
|
Meldrum DR, Gambone JC, Morris MA,
Esposito K, Giugliano D and Ignarro LJ: Lifestyle and metabolic
approaches to maximizing erectile and vascular health. Int J Impot
Res. 24:61–68. 2012.PubMed/NCBI View Article : Google Scholar
|
9
|
Buvat J, Maggi M, Gooren L, Guay AT,
Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A,
et al: Endocrine aspects of male sexual dysfunctions. J Sex Med.
7:1627–1656. 2010.PubMed/NCBI View Article : Google Scholar
|
10
|
García-Cruz E, Leibar-Tamayo A, Romero J,
Piqueras M, Luque P, Cardeñosa O and Alcaraz A: Metabolic syndrome
in men with low testosterone levels: Relationship with
cardiovascular risk factors and comorbidities and with erectile
dysfunction. J Sex Med. 10:2529–2538. 2013.PubMed/NCBI View Article : Google Scholar
|
11
|
Xu H: Obesity and metabolic inflammation.
Drug Discov Today Dis Mech. 10(10)2013.PubMed/NCBI View Article : Google Scholar
|
12
|
Monteiro R and Azevedo I: Chronic
inflammation in obesity and the metabolic syndrome. Mediators
Inflamm. 2010(289645)2010.PubMed/NCBI View Article : Google Scholar
|
13
|
Otis CR, Wamhoff BR and Sturek M:
Hyperglycemia-induced insulin resistance in diabetic dyslipidemic
Yucatan swine. Comp Med. 53:53–64. 2003.PubMed/NCBI
|
14
|
Takeda S, Sato N, Uchio-Yamada K, Sawada
K, Kunieda T, Takeuchi D, Kurinami H, Shinohara M, Rakugi H and
Morishita R: Diabetes-accelerated memory dysfunction via
cerebrovascular inflammation and Abeta deposition in an Alzheimer
mouse model with diabetes. Proc Natl Acad Sci USA. 107:7036–7041.
2010.PubMed/NCBI View Article : Google Scholar
|
15
|
Zhao SJ, Guo CN, Wang MQ, Chen WJ and Zhao
YB: Serum levels of inflammation factors and cognitive performance
in amnestic mild cognitive impairment: A Chinese clinical study.
Cytokine. 57:221–225. 2012.PubMed/NCBI View Article : Google Scholar
|
16
|
Lai KSP, Liu CS, Rau A, Lanctôt KL, Köhler
CA, Pakosh M, Carvalho AF and Herrmann N: Peripheral inflammatory
markers in Alzheimer's disease: A systematic review and
meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry.
88:876–882. 2017.PubMed/NCBI View Article : Google Scholar
|
17
|
Gocmez SS, Şahin TD, Yazir Y, Duruksu G,
Eraldemir FC, Polat S and Utkan T: Resveratrol prevents cognitive
deficits by attenuating oxidative damage and inflammation in rat
model of streptozotocin diabetes induced vascular dementia. Physiol
Behav. 201:198–207. 2019.PubMed/NCBI View Article : Google Scholar
|
18
|
Versari D, Daghini E, Virdis A, Ghiadoni L
and Taddei S: Endothelial dysfunction as a target for prevention of
cardiovascular disease. Diabetes Care. 32 (Suppl 2):S314–S321.
2009.PubMed/NCBI View Article : Google Scholar
|
19
|
Jha NK, Jha SK, Kar R, Nand P, Swati K and
Goswami VK: Nuclear factor-kappa β as a therapeutic target for
Alzheimer's disease. J Neurochem. 150:113–137. 2019.PubMed/NCBI View Article : Google Scholar
|
20
|
Kawahara TLA, Michishita E, Adler AS,
Damian M, Berber E, Lin M, McCord RA, Ongaigui KCL, Boxer LD, Chang
HY, et al: SIRT6 links histone H3 lysine 9 deacetylation to
NF-kappaB-dependent gene expression and organismal life span. Cell.
136:62–74. 2009.PubMed/NCBI View Article : Google Scholar
|
21
|
Natoli G: When sirtuins and NF-kappaB
collide. Cell. 136:19–21. 2009.PubMed/NCBI View Article : Google Scholar
|
22
|
Feng Y, Li X, Zhou W, Lou D, Huang D, Li
Y, Kang Y, Xiang Y, Li T, Zhou W, et al: Regulation of SET gene
expression by NFκB. Mol Neurobiol. 54:4477–4485. 2017.PubMed/NCBI View Article : Google Scholar
|
23
|
Tousian Shandiz H, Razavi BM and
Hosseinzadeh H: Review of Garcinia mangostana and its
Xanthones in Metabolic Syndrome and Related Complications.
Phytother Res. 31:1173–1182. 2017.PubMed/NCBI View
Article : Google Scholar
|
24
|
Ibrahim MY, Hashim NM, Mariod AA, Mohan S,
Abdulla MA, Abdelwahab SI and Arbab IA: α-Mangostin from
Garcinia mangostana Linn: An updated review of its
pharmacological properties. Arab J Chem. 9:317–329. 2016.
|
25
|
Obolskiy D, Pischel I, Siriwatanametanon N
and Heinrich M: Garcinia mangostana L.: A phytochemical and
pharmacological review. Phytother Res. 23:1047–1065.
2009.PubMed/NCBI View
Article : Google Scholar
|
26
|
World Health Organization: Programme on
Traditional Medicine. General guidelines for methodologies on
research and evaluation of traditional medicine. World Health
Organization, 2000.
|
27
|
Suthammarak W, Numpraphrut P, Charoensakdi
R, Neungton N, Tunrungruangtavee V, Jaisupa N, Charoensak S,
Moongkarndi P and Muangpaisan W: Antioxidant-enhancing property of
the polar fraction of mangosteen pericarp extract and evaluation of
its safety in humans. Oxid Med Cell Longev.
2016(1293036)2016.PubMed/NCBI View Article : Google Scholar
|
28
|
Jung HA, Su BN, Keller WJ, Mehta RG and
Kinghorn AD: Antioxidant xanthones from the pericarp of Garcinia
mangostana (Mangosteen). J Agric Food Chem. 54:2077–2082.
2006.PubMed/NCBI View Article : Google Scholar
|
29
|
Wang MH, Zhang KJ, Gu QL, Bi XL and Wang
JX: Pharmacology of mangostins and their derivatives: A
comprehensive review. Chin J Nat Med. 15:81–93. 2017.PubMed/NCBI View Article : Google Scholar
|
30
|
Bumrungpert A, Kalpravidh RW, Chuang CC,
Overman A, Martinez K, Kennedy A and McIntosh M: Xanthones from
mangosteen inhibit inflammation in human macrophages and in human
adipocytes exposed to macrophage-conditioned media. J Nutr.
140:842–847. 2010.PubMed/NCBI View Article : Google Scholar
|
31
|
Cho BO, Ryu HW, So Y, Lee CW, Jin CH, Yook
HS, Jeong YW, Park JC and Jeong IY: Anti-inflammatory effect of
mangostenone F in lipopolysaccharide-stimulated RAW264.7
macrophages by suppressing NF-κB and MAPK activation. Biomol Ther
(Seoul). 22:288–294. 2014.PubMed/NCBI View Article : Google Scholar
|
32
|
Syam S, Bustamam A, Abdullah R, Sukari MA,
Hashim NM, Mohan S, Looi CY, Wong WF, Yahayu MA and Abdelwahab SI:
β Mangostin suppress LPS-induced inflammatory response in RAW 264.7
macrophages in vitro and carrageenan-induced peritonitis in vivo. J
Ethnopharmacol. 153:435–445. 2014.PubMed/NCBI View Article : Google Scholar
|
33
|
Liu Q, Li D, Wang A, Dong Z, Yin S, Zhang
Q, Ye Y, Li L and Lin L: Nitric oxide inhibitory xanthones from the
pericarps of Garcinia mangostana. Phytochemistry.
131:115–123. 2016.PubMed/NCBI View Article : Google Scholar
|
34
|
Chin YW, Jung HA, Chai H, Keller WJ and
Kinghorn AD: Xanthones with quinone reductase-inducing activity
from the fruits of Garcinia mangostana (Mangosteen).
Phytochemistry. 69:754–758. 2008.PubMed/NCBI View Article : Google Scholar
|
35
|
Taher M, Tg Zakaria TMFS, Susanti D and
Zakaria ZA: Hypoglycaemic activity of ethanolic extract of
Garcinia mangostana Linn. in normoglycaemic and
streptozotocin-induced diabetic rats. BMC Complement Altern Med.
16(135)2016.PubMed/NCBI View Article : Google Scholar
|
36
|
Liu QY, Wang YT and Lin LG: New insights
into the anti-obesity activity of xanthones from Garcinia
mangostana. Food Funct. 6:383–393. 2015.PubMed/NCBI View Article : Google Scholar
|
37
|
Sukatta U, Takenaka M, Ono H, Okadome H,
Sotome I, Nanayama K, Thanapase W and Isobe S: Distribution of
major xanthones in the pericarp, aril, and yellow gum of mangosteen
(Garcinia mangostana Linn.) fruit and their contribution to
antioxidative activity. Biosci Biotechnol Biochem. 77:984–987.
2013.PubMed/NCBI View Article : Google Scholar
|
38
|
Ashton MM, Dean OM, Walker AJ, Bortolasci
CC, Ng CH, Hopwood M, Harvey BH, Möller M, McGrath JJ, Marx W, et
al: The therapeutic potential of mangosteen pericarp as an
adjunctive therapy for bipolar disorder and schizophrenia. Front
Psychiatry. 10(115)2019.PubMed/NCBI View Article : Google Scholar
|
39
|
Wihastuti TA, Sargowo D, Tjokroprawiro A,
Permatasari N, Widodo MA and Soeharto S: Vasa vasorum
anti-angiogenesis through H2O2, HIF-1α,
NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract
(Garcinia mangostana Linn) in hypercholesterol-diet-given
Rattus norvegicus Wistar strain. Vasc Health Risk Manag.
10:523–531. 2014.PubMed/NCBI View Article : Google Scholar
|
40
|
Sattayasai J, Chaonapan P, Arkaravichie T,
Soi-Ampornkul R, Junnu S, Charoensilp P, Samer J, Jantaravinid J,
Masaratana P, Suktitipat B, et al: Protective effects of mangosteen
extract on H2O2-induced cytotoxicity in
SK-N-SH cells and scopolamine-induced memory impairment in mice.
PLoS One. 8(e85053)2013.PubMed/NCBI View Article : Google Scholar
|
41
|
Council NR: Guide for the Care and Use of
Laboratory Animals. 8th edition. The National Academies Press,
Washington, DC, 2011.
|
42
|
Janardhanan S, Mahendra J, Mahendra L and
Devarajan N: Cytotoxic effects of mangosteen pericarp extracts on
oral cancer and cervical cancer cells. Asian Pac J Cancer Prev.
21:2577–2583. 2020.PubMed/NCBI View Article : Google Scholar
|
43
|
Saggu R, Schumacher T, Gerich F, Rakers C,
Tai K, Delekate A and Petzold GC: Astroglial NF-κB contributes to
white matter damage and cognitive impairment in a mouse model of
vascular dementia. Acta Neuropathol Commun. 4(76)2016.PubMed/NCBI View Article : Google Scholar
|
44
|
Mattson MP and Camandola S: NF-kappaB in
neuronal plasticity and neurodegenerative disorders. J Clin Invest.
107:247–254. 2001.PubMed/NCBI View Article : Google Scholar
|
45
|
Albensi BC and Mattson MP: Evidence for
the involvement of TNF and NF-kappaB in hippocampal synaptic
plasticity. Synapse. 35:151–159. 2000.PubMed/NCBI View Article : Google Scholar
|
46
|
Liu T, Zhang L, Joo D and Sun SC: NF-κB
signaling in inflammation. Signal Transduct Target Ther.
2(17023)2017.PubMed/NCBI View Article : Google Scholar
|
47
|
Schwaninger M, Sallmann S, Petersen N,
Schneider A, Prinz S, Libermann TA and Spranger M: Bradykinin
induces interleukin-6 expression in astrocytes through activation
of nuclear factor-kappaB. J Neurochem. 73:1461–1466.
1999.PubMed/NCBI View Article : Google Scholar
|
48
|
Brüünsgaard H and Pedersen BK: Age-related
inflammatory cytokines and disease. Immunol Allergy Clin North Am.
23:15–39. 2003.PubMed/NCBI View Article : Google Scholar
|
49
|
Tarkowski E, Liljeroth AM, Minthon L,
Tarkowski A, Wallin A and Blennow K: Cerebral pattern of pro- and
anti-inflammatory cytokines in dementias. Brain Res Bull.
61:255–260. 2003.PubMed/NCBI View Article : Google Scholar
|
50
|
Schuitemaker A, Dik MG, Veerhuis R,
Scheltens P, Schoonenboom NS, Hack CE, Blankenstein MA and Jonker
C: Inflammatory markers in AD and MCI patients with different
biomarker profiles. Neurobiol Aging. 30:1885–1889. 2009.PubMed/NCBI View Article : Google Scholar
|
51
|
Marsland AL, Gianaros PJ, Abramowitch SM,
Manuck SB and Hariri AR: Interleukin-6 covaries inversely with
hippocampal grey matter volume in middle-aged adults. Biol
Psychiatry. 64:484–490. 2008.PubMed/NCBI View Article : Google Scholar
|
52
|
Arrick DM, Sun H, Patel KP and Mayhan WG:
Chronic resveratrol treatment restores vascular responsiveness of
cerebral arterioles in type 1 diabetic rats. Am J Physiol Heart
Circ Physiol. 301:H696–H703. 2011.PubMed/NCBI View Article : Google Scholar
|
53
|
Hadi HAR and Suwaidi JA: Endothelial
dysfunction in diabetes mellitus. Vasc Health Risk Manag.
3:853–876. 2007.PubMed/NCBI
|
54
|
Sharma B and Singh N: Pitavastatin and
4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive
dysfunction in vascular dementia during experimental diabetes. Curr
Neurovasc Res. 7:180–191. 2010.PubMed/NCBI View Article : Google Scholar
|
55
|
Sharma B and Singh N: Attenuation of
vascular dementia by sodium butyrate in streptozotocin diabetic
rats. Psychopharmacology (Berl). 215:677–687. 2011.PubMed/NCBI View Article : Google Scholar
|
56
|
Biessels GJ, van der Heide LP, Kamal A,
Bleys RL and Gispen WH: Ageing and diabetes: Implications for brain
function. Eur J Pharmacol. 441:1–14. 2002.PubMed/NCBI View Article : Google Scholar
|
57
|
Bumrungpert A, Kalpravidh RW,
Chitchumroonchokchai C, Chuang CC, West T, Kennedy A and McIntosh
M: Xanthones from mangosteen prevent lipopolysaccharide-mediated
inflammation and insulin resistance in primary cultures of human
adipocytes. J Nutr. 139:1185–1191. 2009.PubMed/NCBI View Article : Google Scholar
|
58
|
Negi JS, Bisht VK, Singh P, Rawat MS and
Joshi GP: Naturally occurring xanthones: Chemistry and biology. J
Appl Chem. 2013(621459)2013.
|
59
|
Quan GH, Oh SR, Kim JH, Lee HK, Kinghorn
AD and Chin YW: Xanthone constituents of the fruits of Garcinia
mangostana with anticomplement activity. Phytother Res.
24:1575–1577. 2010.PubMed/NCBI View Article : Google Scholar
|
60
|
Li L, Brunner I, Han AR, Hamburger M,
Kinghorn AD, Frye R and Butterweck V: Pharmacokinetics of
α-mangostin in rats after intravenous and oral application. Mol
Nutr Food Res. 55 (Suppl 1):S67–S74. 2011.PubMed/NCBI View Article : Google Scholar
|
61
|
Syamsudin F and Rahayu L: HPLC Analysis
mangostin after orally administration in rats. Asian J Chem.
22:6729–6733. 2010.
|
62
|
Foti RS, Pearson JT, Rock DA, Wahlstrom JL
and Wienkers LC: In vitro inhibition of multiple cytochrome P450
isoforms by xanthone derivatives from mangosteen extract. Drug
Metab Dispos. 37:1848–1855. 2009.PubMed/NCBI View Article : Google Scholar
|
63
|
Li L, Han AR, Kinghorn AD, Frye RF,
Derendorf H and Butterweck V: Pharmacokinetic properties of pure
xanthones in comparison to a mangosteen fruit extract in rats.
Planta Med. 79:646–653. 2013.PubMed/NCBI View Article : Google Scholar
|
64
|
Chitchumroonchokchai C, Riedl KM,
Suksumrarn S, Clinton SK, Kinghorn AD and Failla ML: Xanthones in
mangosteen juice are absorbed and partially conjugated by healthy
adults. J Nutr. 142:675–680. 2012.PubMed/NCBI View Article : Google Scholar
|
65
|
Chitchumroonchokchai C, Thomas-Ahner JM,
Li J, Riedl KM, Nontakham J, Suksumrarn S, Clinton SK, Kinghorn AD
and Failla ML: Anti-tumorigenicity of dietary α-mangostin in an
HT-29 colon cell xenograft model and the tissue distribution of
xanthones and their phase II metabolites. Mol Nutr Food Res.
57:203–211. 2013.PubMed/NCBI View Article : Google Scholar
|
66
|
Chen L, Zhang J, Zhang Y, Wang Y and Wang
B: Improvement of inflammatory responses associated with NF-κB
pathway in kidneys from diabetic rats. Inflamm Res. 57:199–204.
2008.PubMed/NCBI View Article : Google Scholar
|
67
|
Tewtrakul S, Wattanapiromsakul C and
Mahabusarakam W: Effects of compounds from Garcinia
mangostana on inflammatory mediators in RAW264.7 macrophage
cells. J Ethnopharmacol. 121:379–382. 2009.PubMed/NCBI View Article : Google Scholar
|